Topic: United States

Diabetes may shorten working life

NEW YORK (Reuters Health) - People with diabetes may leave the workforce sooner than employees without diabetes -- suggesting, French researchers say, that the common disease could be taking a large economic toll.Among more than 3,000 employees of France's national gas and ...

Common drug combo spikes blood sugar: study

An anti-depressant and a cholesterol lowering drug, taken together by as many as one million people in the United States, may cause a spike in blood sugar levels, researchers said Wednesday.Paxil and the anti-cholesterol drug Pravachol do not have this effect when ...

Gluten not linked to babies' risk of diabetes: study

NEW YORK (Reuters Health) - For babies at higher risk of childhood diabetes because of family history or genes, a gluten-free diet in the first year of life does not lower the chances of developing the disease, German researchers report.The findings undercut ...

Shire announces deal to buy US group for $750 mln

British pharmaceuticals group Shire on Wednesday said it had agreed to buy US company and tissue repair specialist Advanced BioHealing for $750 million (526 million euros) in cash.Under the deal, Shire will acquire the US group's skin substitute product Dermagraft, which is ...

People with diabetes at higher risk for cancer: study

NEW YORK (Reuters Life!) - People with diabetes are at higher risk for certain cancers than those without the blood sugar disease, including colon and pancreatic cancer for men and breast cancer for women, according to a U.S. study.Based on a telephone ...

Supervised exercise most effective for diabetics

CHICAGO (Reuters) - Diabetics get the most benefit when they exercise more than 150 minutes per week in a supervised fitness or exercise program tailored to their needs, an analysis released on Tuesday suggests.The findings, published in the Journal of the American ...

Study backs new drug for typhoid in poor countries

LONDON (Reuters) - A large trial comparing treatments for typhoid has backed the use of gatifloxacin, an antibiotic launched by Bristol Myers Squibb in the United States but withdrawn amid worries about side effects.The trial, conducted in Kathmandu, Nepal, analyzed gatifloxacin, which ...

Diabetic completes first-ever polar flight of its kind

ANCHORAGE, Alaska (Reuters) - Former British Royal Air Force pilot Douglas Cairns succeeded in flying his light plane to the North Pole and landing it there this week, overcoming strong headwinds, the failure of his satellite-based navigation system and his diabetes to ...
Kidney failure is a main complication of diabetes, but a lab study on mice showed that a high-fat, low-carbohydrate diet could reverse that in eight weeks, US researchers said Wednesday.The extreme food plan is known as a ketogenic diet and is often ...

Lilly, Amylin diabetes drug wins EU recommendation

LONDON (Reuters) - An experimental diabetes medicine from Eli Lilly and Amylin Pharmaceuticals, that patients need to inject only once a week, has been recommended for approval by European regulators.The European Medicines Agency said on Friday that Bydureon -- a longer-acting version ...